A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer

Part of paid clinical trials in Tucson, Arizona.

Sponsor
Bristol-Myers Squibb
Study ID
NCT05005273
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Nivolumab — DRUG
    Specified dose on specified days
  • Ipilimumab — DRUG
    Specified dose on specified days
  • BMS-986207 — DRUG
    Specified dose on specified days
  • Placebo — OTHER
    Specified dose on specified days

Study Details

The purpose of this study is to determine the safety and efficacy of BMS-986207 in combination with nivolumab and ipilimumab as first-line treatment for participants with stage IV non-small cell lung cancer (NSCLC).

Key Dates

First listed
Aug 13, 2021
Start date
Oct 3, 2022
Status verified
Jan 2024
Primary completion
Dec 27, 2022
Completion
Dec 27, 2022

Study Design

Enrollment
1 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Arm A
  • Experimental: Arm B

Primary Outcome Measure

Progression Free Survival by BICR [ Time Frame: From first dose to progression or death, 2.3 months ]

Locations (17)

FacilityCityStateZIPSite coordinators
Local Institution - 0080TucsonArizona85719-
Local Institution - 0051Fountain ValleyCalifornia92708-
Local Institution - 0070Fort MyersFlorida33901-
Local Institution - 0073GainesvilleFlorida32610-
Local Institution - 0036Orange CityFlorida32763-
Local Institution - 0045PensacolaFlorida32504-
Local InstitutionPort Saint LucieFlorida34952-
Local Institution - 0068St. PetersburgFlorida33705-
Local InstitutionTallahasseeFlorida32308-
Local InstitutionWest Palm BeachFlorida33401-
Local Institution - 0081BoiseIdaho83706-
Local Institution - 0077Coeur d'AleneIdaho83214-
Local Institution - 0074EdgewoodKentucky41017-
Local Institution - 0002Ann ArborMichigan48109-
Local Institution - 0049BrooklynNew York11220-
Local Institution - 0012CharlestonSouth Carolina29414-
Local Institution - 0053MilwaukeeWisconsin53226-

Find similar trials in Tucson, AZ

Nationwide
Lung cancer trialsOncology trialsLung oncology trialsLung disease trials
By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
Local Institution - 0080· Tucson, AZLocal Institution - 0051· Fountain Valley, CALocal Institution - 0070· Fort Myers, FLLocal Institution - 0073· Gainesville, FLLocal Institution - 0036· Orange City, FLLocal Institution - 0045· Pensacola, FL

Related Studies